Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Asimenia Angelidou, M.D.

Co-Author

This page shows the publications co-authored by Asimenia Angelidou and Al Ozonoff.
Connection Strength

0.850
  1. Precision Vaccine Adjuvants for Older Adults: A Scoping Review. Clin Infect Dis. 2022 Aug 15; 75(Supplement_1):S72-S80.
    View in: PubMed
    Score: 0.248
  2. Human Newborn Monocytes Demonstrate Distinct BCG-Induced Primary and Trained Innate Cytokine Production and Metabolic Activation In Vitro. Front Immunol. 2021; 12:674334.
    View in: PubMed
    Score: 0.230
  3. Licensed Bacille Calmette-Guérin (BCG) formulations differ markedly in bacterial viability, RNA content and innate immune activation. Vaccine. 2020 02 24; 38(9):2229-2240.
    View in: PubMed
    Score: 0.208
  4. Bacille Calmette-Guérin vaccine reprograms human neonatal lipid metabolism in vivo and in vitro. Cell Rep. 2022 05 03; 39(5):110772.
    View in: PubMed
    Score: 0.061
  5. Preparing for Life: Plasma Proteome Changes and Immune System Development During the First Week of Human Life. Front Immunol. 2020; 11:578505.
    View in: PubMed
    Score: 0.055
  6. Dynamic molecular changes during the first week of human life follow a robust developmental trajectory. Nat Commun. 2019 03 12; 10(1):1092.
    View in: PubMed
    Score: 0.049
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.